ROTAVIRUS INFECTION. HOW TO REALLY PROTECT CHILDREN FROM SEVERE GASTROENTERITIS?
https://doi.org/10.15690/pf.v10i5.817
Abstract
According to the statistics of the recent 5 years, the share of rotavirus gastroenterites is 44-47% of all acute intestinal infections in children under 5 years of age in the Russian Federation. Up to 5% of mortality rate in children under 5 years of age is connected with rotavirus gastroenteritis. Rotavirus gastroenteritis takes an especially severe course in children of 6-24 months of age. The only reliable method of preventing this infection is vaccination. The authors present information on the rotavirus strains dominant in Russia and abroad, efficacy and safety of immunization with a pentavalent vaccine and the recommended schemes of its administration. This vaccine is registered in the Russian Federation; it is to be first used in the nearest future.
About the Authors
T. A. Grechukha
Scientific Center of Children’s Health, Moscow
Russian Federation
MD, senior research scientist, immunologist of the vaccinal prevention department for children with health deviations of the SCCH
Russian Federation
MD, senior research scientist, immunologist of the vaccinal prevention department for children with health deviations of the SCCH
M. G. Galitskaya
Scientific Center of Children’s Health, Moscow
Russian Federation
Russian Federation
A. G. Gayvoronskaya
Scientific Center of Children’s Health, Moscow
Russian Federation
Russian Federation
L. S. Namazova-Baranova
Scientific Center of Children’s Health, Moscow, Russian Federation
First Sechenov Moscow State Medical University, Russian Federation
Pirogov Russian National Medical Research University, Moscow, Russian Federation
Russian Federation
Russian Federation
References
1. Arvin A. M., Greenberg H. B. Virology. 2006; 344: 240–249.
2. Centers for disease control and Prevention. Morb Mortal Wkly Rep. 2006; 55 (RR-12): 1–13.
3. Banyia K. et al. Vaccine. 2012; 30S: A122–A130.
4. Podkolzin A. T. et al. Hospital-Based Surveillance of Rotavirus and other Viral Agents of Diarrhea in Children and Adults in
5. Russia, 2005–2007. The Journal of Infectious Diseases. 2009; 200: S228–33.
6. Centers for disease control and Prevention. Morb Mortal Wkly Rep. 2009; 58 (RR-2): 1–25.
7. Velazquez F. R. et al. N Engl J Med. 1996; 335: 1022–1028.
8. Isla Ogilvie, Hanane Khoury, Antoine C., El Khoury et al. Burden of rotavirus gastroenteritis in the pediatric population in Central and
9. Eastern Europe. Human Vaccines. 2011 May; 7 (5): 523–533.
10. Weekly epidemiological record. 2008; 47: 421–425.
11. URL: http://www.rospotrebnadzor.ru
12. Иммунопрофилактика-2011. 3-е изд. Под ред. В. К. Таточенко, Н. А. Озерецкого, А. М. Федорова. Изд.: ИПК «Контент-пресс». 2011.
13. URL: http://www.rotateq.com
14. Goveia M. G. et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007; 26: 1099–1104.
15. The results of the 31-st Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID). Milan, Italy. May 28 June 1. 2013.
16. Rotavirus vaccines. WHO position paper. 2013 Jan 5; 88: 49–64. URL: http://www.who.int/wer
17. Намазова-Баранова Л. С. Научные исследования и инфраструктура платформы «Педиатрия». Педиатрическая фармакология. 2012; 9 (4): 15–24.
Review
For citations:
Grechukha T.A., Galitskaya M.G., Gayvoronskaya A.G., Namazova-Baranova L.S. ROTAVIRUS INFECTION. HOW TO REALLY PROTECT CHILDREN FROM SEVERE GASTROENTERITIS? Pediatric pharmacology. 2013;10(5):14-17. https://doi.org/10.15690/pf.v10i5.817
Views:
835
Email this article 